证券代码：301584 证券简称：建发致新 公告编号：2025-002 上海建发致新医疗科技集团股份有限公司 关于签署募集资金监管协议的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在任何虚假 记载、误导性陈述或者重大遗漏。 一、募集资金的情况概述 经中国证券监督管理委员会（以下简称"中国证监会"）《关于同意上海建 发致新医疗科技集团股份有限公司首次公开发行股票注册的批复》（证监许可 [2025]1337号）同意注册，上海建发致新医疗科技集团股份有限公司（以下简称 "公司"）首次公开发行人民币普通股（A股）63,193,277股,发行价格为人民币 7.05元/股，募集资金总额445,512,602.85元，扣除相关发行费用后实际募集资 金净额为人民币363,334,464.32元。上述募集资金已于2025年09月22日划至公司 指定账户。经容诚会计师事务所（特殊普通合伙）对募集资金到位情况进行审验， 并出具容诚验字[2025]361Z0047号《验资报告》。 二、《募集资金监管协议》的签署情况和募集资金专户的开立情况 为规范公司募集资金管理，保护投资者权益，根据中国证监会《上市公司募 集资金监 ...

Core Insights - The pharmaceutical commercial sector saw an increase of 0.83% on October 22, with Jianfa Zhixin leading the gains [1] - The Shanghai Composite Index closed at 3913.76, down 0.07%, while the Shenzhen Component Index closed at 12996.61, down 0.62% [1] Stock Performance - Jianfa Zhixin (301584) closed at 31.00, up 7.19% with a trading volume of 238,100 shares and a transaction value of 734 million [1] - Guoyao Shares (600511) closed at 29.89, up 3.75% with a trading volume of 180,500 shares and a transaction value of 539 million [1] - Zhejiang Nongyuan (000705) closed at 9.81, up 3.05% with a trading volume of 117,170 shares and a transaction value of 168 million [1] - Other notable stocks include Jiashitang (002462) up 1.51%, Daclin (603233) up 1.34%, and Guofa Shares (600538) up 1.20% [1] Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 98.42 million from institutional investors and 51.45 million from retail investors, while individual investors saw a net inflow of 150 million [2] - The capital flow for key stocks shows varying trends, with Shanghai Pharmaceuticals (601607) seeing a net inflow of 31.94 million from institutional investors [3] - Jianfa Zhixin (301584) had a net inflow of 18.64 million from institutional investors but a net outflow of 2.07 million from retail investors [3]

Market Overview - The pharmaceutical commercial sector increased by 0.55% on October 21, with First Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 3916.33, up 1.36%, while the Shenzhen Component Index closed at 13077.32, up 2.06% [1] Stock Performance - First Pharmaceutical (600833) closed at 13.64, up 2.48% with a trading volume of 58,500 shares and a transaction value of 79.03 million yuan [1] - Other notable performers included: - Haiwang Biological (000078) at 2.55, up 2.41% [1] - HeFu China (603122) at 6.55, up 2.34% [1] - Ruikang Pharmaceutical (002589) at 2.93, up 2.09% [1] - Daclin (603233) at 18.67, up 1.52% with a transaction value of 293 million yuan [1] Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 105 million yuan from institutional investors and 110 million yuan from speculative funds, while retail investors saw a net inflow of 215 million yuan [2] - The capital flow for individual stocks showed mixed results, with China Pharmaceutical (600056) seeing a net inflow of 28.32 million yuan from institutional investors [3] Individual Stock Capital Flow - Key stocks with significant capital flow include: - China Pharmaceutical (600056) with a net inflow of 28.32 million yuan from institutional investors [3] - Jiuzhoutong (600998) with a net inflow of 24.77 million yuan from institutional investors [3] - Shanghai Pharmaceutical (601607) with a net inflow of 11.37 million yuan from institutional investors [3]

Market Overview - As of October 20, the Shanghai Composite Index closed at 3863.89 points, up 24.14 points, with a gain of 0.63% [1] - The Shenzhen Component Index closed at 12813.21 points, up 124.27 points, with a gain of 0.98% [1] - The ChiNext Index closed at 2993.45 points, up 58.09 points, with a gain of 1.98% [1] Stock Performance - A total of 53 A-shares had a turnover rate exceeding 20%, with C Dao Sheng reaching over 50% [1] - C Dao Sheng's closing price was 25.96 yuan, with a turnover rate of 57.83% and a decline of 12.53% [1] - Matrix Co. closed at 26.65 yuan, with a turnover rate of 43.42% and an increase of 2.38% [1] - Yunhan Chip City closed at 164.31 yuan, with a turnover rate of 39.89% and a decrease of 1.02% [1] - Other notable stocks include: - Haichuang Ruitong: 54.38 yuan, 37.40% turnover, 0.15% increase [1] - Jianfa Zhixin: 29.30 yuan, 36.97% turnover, 4.46% increase [1] - Feiwo Technology: 45.78 yuan, 34.92% turnover, 20.00% increase [1] Additional Notable Stocks - Chuling Information: 25.98 yuan, 33.92% turnover, 12.42% increase [1] - Changjiang Nengke: 17.56 yuan, 32.65% turnover, 5.03% decrease [1] - Huifeng Diamond: 39.32 yuan, 32.03% turnover, 29.98% increase [1] - Lanfeng Biochemical: 8.05 yuan, 31.49% turnover, 4.62% decrease [1] - Shandong Molong: 7.04 yuan, 30.78% turnover, 3.83% increase [1]

具体来看，今日上榜的营业部中，共有7家机构专用席位现身，即买一、买二、买三、买四、买五、卖 一、卖二、卖三、卖四、卖五，合计买入金额5598.56万元，卖出金额5845.03万元，合计净卖出246.47 万元。 建发致新今日上涨4.46%，全天换手率36.97%，成交额5.34亿元，振幅7.25%。龙虎榜数据显示，机构净 卖出246.47万元。 深交所公开信息显示，当日该股因日换手率达36.97%上榜，机构专用席位净卖出246.47万元。 | 买/卖 | 会员营业部名称 | 买入金额（万元） | 卖出金额（万元） | | --- | --- | --- | --- | | 买一 | 机构专用 | 1518.74 | 391.84 | | 买二 | 机构专用 | 1282.60 | 562.88 | | 买三 | 机构专用 | 1015.77 | 1191.84 | | 买四 | 机构专用 | 935.11 | 643.69 | | 买五 | 机构专用 | 668.53 | 39.86 | | 卖一 | 机构专用 | 145.75 | 2523.27 | | 卖二 | 机构专用 | 1015.77 | 1191 ...

Market Overview - The medical consumables supply chain SPD sector increased by 0.41% compared to the previous trading day, with Jianfa Zhixin leading the gains [1] - The Shanghai Composite Index closed at 3863.89, up 0.63%, while the Shenzhen Component Index closed at 12813.21, up 0.98% [1] Stock Performance - Jianfa Zhixin (301584) closed at 29.30, up 4.46% with a trading volume of 186,400 shares and a transaction value of 534 million [1] - Dajia Weikang (301126) closed at 11.75, up 3.07% with a trading volume of 53,500 shares and a transaction value of 62.22 million [1] - Jianmo Information (605186) closed at 19.55, up 2.68% with a trading volume of 17,200 shares and a transaction value of 33.43 million [1] - Other notable performers include Hefei China (603122) up 1.91%, Langma Information (300288) up 1.48%, and Seli Medical (603716) up 1.48% [1] Capital Flow - The SPD sector experienced a net outflow of 43.97 million from institutional investors, while retail investors saw a net inflow of 16.33 million [2] - The sector's overall capital flow indicates a mixed sentiment, with institutional investors pulling back while retail investors are more active [2] Individual Stock Capital Flow - Seli Medical (603716) had a net inflow of 12.83 million from institutional investors, but a net outflow of 12.61 million from speculative funds [3] - Dajia Weikang (301126) saw a net inflow of 5.24 million from speculative funds, but a net outflow of 5.91 million from retail investors [3] - Huadong Pharmaceutical (000963) had a net inflow of 2.37 million from speculative funds, while retail investors experienced a net outflow of 4.64 million [3]

格隆汇10月20日丨建发致新(301584.SZ)在互动平台表示，公司目前在达芬奇手术机器人产品经营活动 中，承担分销商角色，该产品品牌系海外Intuitive Surgical, Inc.所有，并非公司研发和生产。公司目前没 有医用机器人方面的技术研发储备和投资计划。 ...

每经AI快讯，有投资者在投资者互动平台提问：公司重要产品，达芬奇医疗机器人系统是不是自主研 发，目前专用医用机器人领域占比多少？ 建发致新（301584.SZ）10月20日在投资者互动平台表示，公司目前在达芬奇手术机器人产品经营活动 中，承担分销商角色，该产品品牌系海外Intuitive Surgical, Inc.所有，并非公司研发和生产。公司目前没 有医用机器人方面的技术研发储备和投资计划。 （记者 王瀚黎） ...

Core Points - The company has changed its investor contact number to improve investor relations management [1] - The new investor contact number is 021-60430629, replacing the old number 021-60430840 [1] - Other contact information, such as the company's registered address and email, remains unchanged [1]

证券日报网讯建发致新（301584）10月17日在互动平台回答投资者提问时表示，公司主营业务为医疗器 械(如医疗高值耗材和IVD诊断产品)的分销和直销活动，目前不涉及创新药项目的销售活动。 ...